Brilliant VA by Sharanya Ramesh for this week’s NephJC on safety and efficacy of fully closed-loop insulin therapy in patients with type 2 diabetes requiring dialysis.
Background
This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
Background
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
Background
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
